May 3-4, 2023. T-CURX to attend and to present at LSX World Congress in London

T-CURX will participate at the LSX World Congress Biotech in London, May 3-4, 2023

T-CURX, a new leader in the field of devloping next-generation CAR-T cell therapies for cancer patients, will participate at the 2023 LSX World Congress Biotech, taking place from May 3-4, 2023 at the Business Design Centre, London (55 Upper Street, London N1 0QH). T-CURX CEO, Ulf Grawunder, will present T-CURX strategies and plans to provide better, more cost-effective and highly scalable CAR-T therapies for cancer patients at a company presentation scheduled on May 3, at 3:45 p.m. in the Biotech Showcase.

In addition the leadership team of T-CURX, including Ulf, T-CURX CFO, Tom Loeser and T-CURX Global Head Business Development, Caroline Burger, will be available for meetings on both days of the conference.

For more information on this congress, please visit the conference's web-site at: https://www.lsxleaders.com/lsx-world-congress